Cardiomyopathy, Hypertrophic
"Cardiomyopathy, Hypertrophic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).
| Descriptor ID |
D002312
|
| MeSH Number(s) |
C14.280.238.100 C14.280.484.150.070.160
|
| Concept/Terms |
Cardiomyopathy, Hypertrophic- Cardiomyopathy, Hypertrophic
- Cardiomyopathies, Hypertrophic
- Hypertrophic Cardiomyopathies
- Hypertrophic Cardiomyopathy
- Cardiomyopathy, Hypertrophic Obstructive
- Cardiomyopathies, Hypertrophic Obstructive
- Hypertrophic Obstructive Cardiomyopathies
- Hypertrophic Obstructive Cardiomyopathy
- Obstructive Cardiomyopathies, Hypertrophic
- Obstructive Cardiomyopathy, Hypertrophic
|
Below are MeSH descriptors whose meaning is more general than "Cardiomyopathy, Hypertrophic".
Below are MeSH descriptors whose meaning is more specific than "Cardiomyopathy, Hypertrophic".
This graph shows the total number of publications written about "Cardiomyopathy, Hypertrophic" by people in this website by year, and whether "Cardiomyopathy, Hypertrophic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 1 | 0 | 1 |
| 2017 | 29 | 3 | 32 |
| 2018 | 33 | 5 | 38 |
| 2019 | 13 | 2 | 15 |
| 2020 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Cardiomyopathy, Hypertrophic" by people in Profiles.
-
A cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients. Sci Rep. 2021 08 02; 11(1):15667.
-
Severe SARS-CoV-2 Infection in a Cat with Hypertrophic Cardiomyopathy. Viruses. 2021 07 31; 13(8).
-
Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain. Proc Natl Acad Sci U S A. 2020 10 06; 117(40):24790-24793.
-
Telehealth monitoring for hypertrophic cardiomyopathy and amyloid cardiomyopathy patients: lessons from the coronavirus disease 2019 lockdown in Italy. J Cardiovasc Med (Hagerstown). 2020 08; 21(8):622-623.
-
Myocyte-Specific Upregulation of ACE2 in Cardiovascular Disease: Implications for SARS-CoV-2-Mediated Myocarditis. Circulation. 2020 08 18; 142(7):708-710.
-
Marked Up-Regulation of ACE2 in Hearts of Patients With Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2-Mediated COVID-19. Mayo Clin Proc. 2020 07; 95(7):1354-1368.
-
CMR Assessment of Myocyte Disarray in HCM: Matching Another Piece in the Puzzle. J Am Coll Cardiol. 2019 10 08; 74(14):1847-1848.
-
The prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy: An updated meta-analysis. Eur J Prev Cardiol. 2020 11; 27(17):1902-1905.
-
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a contemporary reappraisal. EuroIntervention. 2019 Aug 29; 15(5):411-417.
-
Conduction Abnormalities and Long-Term Mortality Following Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2019 08 06; 74(5):645-655.